Van Eck Associates Corp Novo Nordisk A S Transaction History
Van Eck Associates Corp
- $77.4 Billion
- Q1 2025
A detailed history of Van Eck Associates Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Van Eck Associates Corp holds 447,557 shares of NVO stock, worth $30.9 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
447,557
Previous 462,985
3.33%
Holding current value
$30.9 Million
Previous $39.8 Million
21.97%
% of portfolio
0.04%
Previous 0.05%
Shares
32 transactions
Others Institutions Holding NVO
# of Institutions
1,757Shares Held
339MCall Options Held
11MPut Options Held
15.9M-
Jennison Associates LLC18.8MShares$1.3 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.02 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$855 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$850 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$819 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $156B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...